NF kappa B, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease
Research output: Contribution to journal › Article
Colleges, School and Institutes
P>Background/aims Conflicting observations exist concerning the role of nuclear factor kappa B (NF kappa B) in alcoholic liver disease (ALD) in animal models. To date no studies have examined this aspect in human liver tissue. We here assessed cytokines and toll-like receptors (TLRs) expressions in conjunction with NF kappa B activation in non-active end-stage human ALD compared with normal livers and hepatitis C virus (HCV) related end-stage disease. Methods mRNA and protein expression were examined by quantitative PCR and Western blotting, DNA-binding by electrophoretic mobility shift assays and NF kappa B sub-cellular localization by immunofluorescent staining of livers. Results NF kappa B mRNA and protein expression as well as strong DNA-binding were preserved in ALD but significantly down-regulated in HCV compared with normal livers. P50 immunofluorescence was found in hepatocytes and bile ducts in ALD and normal livers, whereas a shift was observed in p65 staining from non-parenchymal cells in normal livers to hepatocytes in ALD. NF kappa B responsive genes mRNA levels IkB alpha and interleukin 6 were significantly higher in ALD compared with HCV. Tumour necrosis factor alpha (TNF alpha), TLRs 3 and 7 mRNA were up-regulated in ALD and HCV compared with normal liver with TNF alpha and TLR7 being the highest in HCV. Strong induction of interferon beta was found in HCV but not in ALD or normal liver tissue. Conclusions Persistent NF kappa B activation together with high pro-inflammatory cytokine expression and upregulation of TLR3 and TLR7 is associated with end-stage ALD in humans and could contribute to disease progression even in absence of alcohol intake.
|Number of pages||10|
|Journal||European journal of clinical investigation|
|Publication status||Published - 1 Jul 2010|
- Alcohol, transcription factor, TNF alpha, IL-6, normal liver, hepatitis C, cirrhosis